goetzpartners securities Limited 28-March-2019 / 19:54 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail […]
Category: Press Releases
28. March 2019
Epigenomics (ECX-DE): 2018 results highlight strong underlying growth momentum
Read more
27. March 2019
Epigenomics AG Reports Results for Financial Year 2018
DGAP-News: Epigenomics AG / Key word(s): Annual Results 27.03.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Results for Financial Year 2018 Berlin (Germany) und San Diego, CA (U.S.A.), March 27, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced the financial results (according […]
15. March 2019
Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. Press release U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and San […]
15. March 2019
Correction of the Corporate News of March 15, 2019, 12:40 pm: Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 14:45 The issuer is solely responsible for the content of this announcement. Correction of the Corporate News of March 15, 2019, 12:40 pm: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying […]
07. January 2019
Epigenomics AG Announces Positive Results from Microsimulation Model
DGAP-News: Epigenomics AG / Key word(s): Scientific publication/Miscellaneous 07.01.2019 / 07:45 The issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Positive Results from Microsimulation Model Berlin (Germany) and San Diego, CA (U.S.A.), January 7, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced that a microsimulation model has been […]
20. December 2018
Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection
DGAP-News: Epigenomics AG / Key word(s): Study/Miscellaneous 20.12.2018 / 15:56 The issuer is solely responsible for the content of this announcement. Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection Berlin (Germany) and San Diego, CA (U.S.A.), 20 December, 2018 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY) today announced the initiation […]